Overview

BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
13C breath di-peptide tests are an effective non-invasive tool to detect pancreatic exocrine function in patients with Chronic Pancreatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Exalenz Bioscience LTD.
Collaborators:
Asian Institute of Gastroenterology, Hyderabad, India
Virginia Commonwealth University